Red Propolis Supplement for Inflammation in People With Chronic Kidney Disease
Tests red propolis against a placebo in adults with chronic kidney disease.
Plain-language title generated from the registry record
Registry title: Red Propolis Supplementation as a Strategy in Chronic Kidney Disease
Key facts
- Where
- Rio de Janeiro, BrazilSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT07597005, who can take part
Where in Brazil
- Denise mafraRio de Janeiro, BrazilTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Universidade Federal Fluminense
- Trial code
- NCT07597005
- Record updated
- 19 May 2026
- Original description
The objective of this study is to evaluate the effects of red propolis on inflammation and oxidative stress in patients with chronic kidney disease on conservative management.Read full original descriptionShow less
Red Propolis as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Chronic Kidney Disease
The objective of this study is to evaluate the effects of red propolis on inflammation and oxidative stress in patients with chronic kidney disease on conservative management.
Inclusion: patients with CKD stages 3-5 under conservative management.
Exclusion: patients with autoimmune and infectious diseases,; patients with cancer, liver disease, and AIDS; pregnant,; lactating,; smoker; patients using antibiotics and antioxidant supplements in the last three months.